Literature DB >> 2000839

Lung cancer in mild steel welders.

K Steenland1, J Beaumont, L Elliot.   

Abstract

To investigate lung cancer risk, the authors conducted a historical cohort mortality study of 4,459 mild steel welders who had been employed at three midwestern plants which manufactured heavy equipment. Follow-up began in the mid-1950s and extended through 1988. All welders had at least 2 years welding experience (average duration, 8.5 years). This cohort had no occupational exposure to asbestos or stainless steel fumes (containing nickel and chromium), two potential confounders in previous welders studies. A comparison population of 4,286 nonwelders, all with at least 2 years employment at the same plants, was also studied. Nonwelders had never been welders and were allowed to have no more than 90 days employment as a painter, foundryman, or machinist. Sampling data collected from 1974-1987 indicated that welders were exposed to 6-7 mg/m3 of total particulate and 3-4 mg/m3 of iron oxide, while nonwelders had negligible exposures to welding fumes. When compared with the United States population, both welders and nonwelders had elevated rates for lung cancer (standardized mortality ratios (SMRs): welders, SMR = 1.07; nonwelders, SMR = 1.17), but neither SMR was significantly elevated. Limited smoking data based on a 1985 survey indicated that both welders and nonwelders smoked more than the United States population, possibly accounting for part of their elevated lung cancer rates. There was no trend of increased risk for welders with increased duration of exposure. The only other cause of death significantly elevated was emphysema among welders. Nonmalignant respiratory disease was not elevated for welders (SMR = 0.96). When welders were compared with nonwelders directly for lung cancer, the rate ratio was 0.90.

Entities:  

Mesh:

Year:  1991        PMID: 2000839     DOI: 10.1093/oxfordjournals.aje.a115866

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  8 in total

Review 1.  Immunotoxicology of arc welding fume: worker and experimental animal studies.

Authors:  Patti C Zeidler-Erdely; Aaron Erdely; James M Antonini
Journal:  J Immunotoxicol       Date:  2012-06-26       Impact factor: 3.000

2.  Evaluation of tumorigenic potential of CeO2 and Fe2O3 engineered nanoparticles by a human cell in vitro screening model.

Authors:  Todd A Stueckle; Donna C Davidson; Raymond Derk; Tiffany G Kornberg; Diane Schwegler-Berry; Sandra V Pirela; Glen Deloid; Philip Demokritou; Sudjit Luanpitpong; Yon Rojanasakul; Liying Wang
Journal:  NanoImpact       Date:  2016-11-22

3.  A mortality study among mild steel and stainless steel welders.

Authors:  J J Moulin; P Wild; J M Haguenoer; D Faucon; R De Gaudemaris; J M Mur; M Mereau; Y Gary; J P Toamain; Y Birembaut
Journal:  Br J Ind Med       Date:  1993-03

4.  Effect of stainless steel manual metal arc welding fume on free radical production, DNA damage, and apoptosis induction.

Authors:  James M Antonini; Stephen S Leonard; Jenny R Roberts; Claudia Solano-Lopez; Shih-Houng Young; Xianglin Shi; Michael D Taylor
Journal:  Mol Cell Biochem       Date:  2005-11       Impact factor: 3.396

5.  Incidence of cancer among Norwegian boiler welders.

Authors:  T E Danielsen; S Langård; A Andersen
Journal:  Occup Environ Med       Date:  1996-04       Impact factor: 4.402

6.  Low dose inflammatory potential of silica particles in human-derived THP-1 macrophage cell culture studies - Mechanism and effects of particle size and iron.

Authors:  Gayatri Premshekharan; Kennedy Nguyen; Hongqiao Zhang; Henry Jay Forman; Valerie Jean Leppert
Journal:  Chem Biol Interact       Date:  2017-05-13       Impact factor: 5.192

7.  Incidence of cancer among welders of mild steel and other shipyard workers.

Authors:  T E Danielsen; S Langård; A Andersen; O Knudsen
Journal:  Br J Ind Med       Date:  1993-12

8.  Exposure to welding fumes increases lung cancer risk among light smokers but not among heavy smokers: evidence from two case-control studies in Montreal.

Authors:  Eric Vallières; Javier Pintos; Jérôme Lavoué; Marie-Élise Parent; Bernard Rachet; Jack Siemiatycki
Journal:  Cancer Med       Date:  2012-06-07       Impact factor: 4.452

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.